• Tribunal upholds CMA’s decision to fine Lexon £1.2m pharmatimes
    March 02, 2021
    The Competition Appeal Tribunal (CAT) has maintained a decision made last year by the UK’s Competition and Markets Authority (CMA) to fine pharmaceutical firm Lexon £1.2m after finding the company guilty of breaking competition law.
  • Two drug firms admit to colluding to keep prices up europeanpharmaceuticalreview
    September 25, 2019
    King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
PharmaSources Customer Service